The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Quinidine Syncope: Paroxysmal Ventricular Fibrillation Occurring during Treatment of Chronic Atrial Arrhythmias
Abstract
QUINIDINE occupies an almost uniqueplace in the therapy of cardiac arrhyth- mias.In the 45-odd years of its clinical use only very few drugs possessing similar pharmacologic properties have been found, but none could match quinidine in its broad ther- apeutic applications.Consequently, the knowledge concerning its clinical use and tox- icity is of considerable importance, for pa- tients who tolerate this drug poorly or are hypersensitive to it may face the prospect of inability to have normal cardiac rhythm re- stored or maintained.The pharmacology and toxicology of quinidine have been the subject of several reviews,'-5 but certain aspects of it are still poorly understood.The purpose of this communication is to focus attention on syncopal attacks occurring during quinidine therapy and apparently related to paroxysms of ventricular flutter or fibrillation.Until very recently such ventricular arrhythmias have been considered a very rare manifestation of quinidine toxicity,5 yet they may well be oc- curring quite frequently, unrecognized, in the course of quinidine therapy. Material and MethodsThe report is based on eight cases wiith re- petitive ventricular arrhythmias occurring during conversion of chronic atrial arrhythmias with quinidine, or after conversion of such arrhythmias by electric atrial defibrillation.These cases were observed during a 4-year period in this unit.While the exact number of courses of quinidine administered to patients with atrial arrhyth-
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Method for Terminating Cardiac Arrhythmias: Use of Synchronized Capacitor Discharge
Lown, B. (1986) · JAMA · doi:10.1001/jama.1986.03380050089028 · Cited by 575
Quinidine as a Cause of Sudden Death
Thomson, G. W. (1956) · Circulation · doi:10.1161/01.cir.14.5.757 · Cited by 86
Cr, R.-P., Schrire, V., Beck, W., & Barnard, C. N. (1962) · American Heart Journal · doi:10.1016/0002-8703(62)90002-9 · Cited by 25
Cited by
Drug-induced prolongation of the QT interval
Roden, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032426 · Cited by 1,965
Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular Drugs
Makkar, R. R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510210076031 · Cited by 971
The long QT syndromes: A critical review, new clinical observations and a unifying hypothesis
Jackman, W. M., Friday, K. J., Anderson, J. L., Aliot, E. M., Clark, M., & Lazzara, R. (1988) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(88)90014-x · Cited by 783
hERG K+Channels: Structure, Function, and Clinical Significance
Vandenberg, J. I., Perry, M. D., Perrin, M. J., Mann, S. A., Ke, Y., & Hill, A. P. (2012) · Physiological Reviews · doi:10.1152/physrev.00036.2011 · Cited by 696
Taking the “Idio” out of “Idiosyncratic”: Predicting Torsades de Pointes
RODEN, D. M. (1998) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1998.tb00148.x · Cited by 667
Electrical reversion of cardiac arrhythmias.
Lown, B. (1967) · Heart · doi:10.1136/hrt.29.4.469 · Cited by 660
Prystowsky, E. N., Benson, D. W., Fuster, V., Hart, R. G., Kay, G. N., Myerburg, R. J., Naccarelli, G. V., & Wyse, D. G. (1996) · Circulation · doi:10.1161/01.cir.93.6.1262 · Cited by 635
Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation
Flaker, G. C., Blackshear, J. L., McBride, R., Kronmal, R. A., Halperin, J. L., & Hart, R. G. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90003-6 · Cited by 632
Roden, D. M., Woosley, R. L., & Primm, R. K. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90010-4 · Cited by 488
Haverkamp*, W. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00119-x · Cited by 486
Neal Kay, G., Vance J., P., Joaquin G., A., Richard W., H., & Albert L., W. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80226-5 · Cited by 463
Kannankeril, P., Roden, D. M., & Darbar, D. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003723 · Cited by 440
Antipsychotic-Related QTc Prolongation, Torsade de Pointes and Sudden Death
Haddad, P. M., & Anderson, I. M. (2002) · Drugs · doi:10.2165/00003495-200262110-00006 · Cited by 435
Haverkamp, W. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2249 · Cited by 414
Drici, M. D., Burklow, T. R., Haridasse, V., Glazer, R. I., & Woosley, R. L. (1996) · Circulation · doi:10.1161/01.cir.94.6.1471 · Cited by 372
Gupta, A., Lawrence, A. T., Krishnan, K., Kavinsky, C. J., & Trohman, R. G. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.01.040 · Cited by 362
Roden, D. M., & Hoffman, B. F. (1985) · Circulation Research · doi:10.1161/01.res.56.6.857 · Cited by 340
Saleh, M., Gabriels, J., Chang, D., Soo Kim, B., Mansoor, A., Mahmood, E., Makker, P., Ismail, H., Goldner, B., Willner, J., et al. (2020) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.120.008662 · Cited by 340
Schwartz, P. J., & Woosley, R. L. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.12.063 · Cited by 328
Management of Atrial Fibrillation
Wood, A. J. J., & Pritchett, E. L. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205073261906 · Cited by 325
Long QT syndrome: reduced repolarization reserve and the genetic link
RODEN, D. M. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01589.x · Cited by 322
Diurnal pattern of QTc interval: How long is prolonged?
Molnar, J., Zhang, F., Weiss, J., Ehlert, F. A., & Rosenthal, J. E. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00426-2 · Cited by 312
Flecainide: Its proarrhythmic effect and expected changes on the surface electrocardiogram
Morganroth, J., & Horowitz, L. N. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90509-5 · Cited by 280
Surawicz, B. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90069-7 · Cited by 275
Crijns, H. J., Van Gelder, I. C., Van Gilst, W. H., Hillege, H., Gosselink, A. M., & Lie, K. I. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90828-9 · Cited by 275
Torsade de Pointes Due to Noncardiac Drugs: Most Patients Have Easily Identifiable Risk Factors
Zeltser, D., Justo, D., Halkin, A., Prokhorov, V., Heller, K., & Viskin, S. (2003) · Medicine · doi:10.1097/01.md.0000085057.63483.9b · Cited by 273
Evaluation of Drug-Induced QT Interval Prolongation: Implications for Drug Approval and Labelling
Malik, M., & Camm, A. J. (2001) · Drug Safety · doi:10.2165/00002018-200124050-00001 · Cited by 273
Electrophysiologic Mechanisms of the Long QT Interval Syndromes and Torsade de Pointes
Tan, H. L., Hou, C. J. Y., Lauer, M. R., & Sung, R. J. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-9-199505010-00009 · Cited by 268
Lewis, B. H., Antman, E. M., & Graboys, T. B. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80268-x · Cited by 83
Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias
Hohnloser, S. H., & Zabel, M. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91071-b · Cited by 74
Pharmacologic Treatment of Depression in Patients With Heart Disease
Roose, S. P., & Miyazaki, M. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000163455.43226.bf · Cited by 76
Metadata
- Authors
- SELZER, A., & WRAY, H. W.
- Venue
- Circulation
- Published
- 1964-07
- Volume
- 30
- Issue
- 1
- Pages
- 17-26
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2005411701
- Cited by
- 562
- References
- 3
- FWCI
- 11.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.